Search Ontology:
ChEBI
3,3',5-triiodo-L-thyronine
- Term ID
- CHEBI:18258
- Synonyms
-
- 3,3',5-triiodo-L-thyronine
- 3,5,3'-Triiodo-L-thyronine
- 3,5,3'-Triiodothyronine
- 3,5,3'TRIIODOTHYRONINE
- 4-(4-hydroxy-3-iodophenoxy)-3,5-diiodo-L-phenylalanine
- L-3,3',5-triiodothyronine
- L-3,5,3'-Triiodothyronine
- L-T3
- L-triiodothyronine
- liothyronine
- liothyroninum
- liotironina
- O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine
- T3
- Tertroxin
- Tresitope
- Triiodothyronine
- Definition
- An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
- References
-
- cas:6893-02-3
- drugbank:DB00279
- drugcentral:1585
- hmdb:HMDB0000265
- kegg.compound:C02465
- kegg.drug:D08128
- lincs.smallmolecule:LSM-3991
- pdb-ccd:T3
- pubmed:11738632
- pubmed:15206581
- pubmed:19339791
- reaxys:2710227
- wikipedia.en:Triiodothyronine
- Ontology
- ChEBI ( EBI )
- Resources
- CTD
Phenotype
Phenotype resulting from 3,3',5-triiodo-L-thyronine
Phenotype where environments contain 3,3',5-triiodo-L-thyronine
Phenotype modified by environments containing 3,3',5-triiodo-L-thyronine
Phenotype affecting 3,3',5-triiodo-L-thyronine
Human Disease Model